Hester Pharmaceuticals Seeks Permission to Import Bird Flu Poultry Vaccine

Hester Pharmaceuticals Ltd, a poultry vaccine manufacturer, has applied to the government for permission to import avian influenza vaccines from France and the United States as a precautionary measure against the bird flu outbreak. The company's CEO, Rajiv Gandhi, announced plans to increase production of other poultry vaccines, while also seeking permission to import a flu detection kit from Synbiotics Corp in the US. If granted, Hester will initially import 20-30 million doses of bird flu vaccines, which could be increased depending on the demand. The company is capable of producing a vaccine against bird flu within 60 days of receiving the necessary strain.

Key Takeaways:

• Hester Pharmaceuticals Ltd has applied to the government for permission to import avian influenza vaccines from France and the United States.
• The company plans to increase its production capacity of poultry vaccines to 4.8 billion doses from the current 1.2 billion doses.
• Hester will initially import 20-30 million doses of bird flu vaccines, with the possibility of increasing production depending on the demand.
• The company is seeking permission to import a variety of poultry vaccines, including Trovac-AIV H5, Gallimune Flu H5N9, Fluvac H7, and Gallimune 208 ND + Flu H9 ME.
• Hester Pharmaceuticals can produce a vaccine against bird flu within 60 days of receiving the necessary strain.

Statistics:

• 20-30 million: The initial number of bird flu vaccine doses Hester plans to import.
• 4.8 billion: The increased production capacity of poultry vaccines Hester is aiming for.
• 1.2 billion: The current production capacity of poultry vaccines Hester has.
• 60 days: The time it takes Hester to produce a vaccine against bird flu if granted the necessary strain.

Sources:

• PTI, "Hester seeks permision to import bird flu poultry vaccine" (21 Feb)